# Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Twice or Three Times Daily in Patients With Acute Ankle Sprain

> **NCT00955513** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 242 (actual)

## Conditions studied

- Grade I/II Ankle Sprain

## Interventions

- **DRUG:** diclofenac diethylamine gel 2.32%
- **DRUG:** diclofenac diethylamine gel 2.32%
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00955513
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2012-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00955513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00955513, "Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Twice or Three Times Daily in Patients With Acute Ankle Sprain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00955513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*